NC gets pharma boost; Sustainability on the rise;

> Biogen Idec will build a 180,000-square-foot building in Research Triangle Park, NC. Story

> OTC pain-reliever maker PharmStar will acquire a 24,000-square-foot manufacturing facility in Wilson, NC. Item

> Cross-industry research that includes the chemical/pharma sector shows nearly half of survey respondents have a sustainability initiative under way while 92 percent say their companies believe the initiatives can save money. Article

> Sixty-five of 100 surveyed drugmakers use integrated ERP/quality management systems to put a hold on batches, ensuring that process anomalies don't impact the products shipped. Release

> Caliber Biotherapeutics has opened a plant-made pharma manufacturing facility in Bryan, TX, that it claims will produce 10 to 100 million low-cost vaccine doses per month. Story

> Archer Daniels Midland is refining processes to produce bio-based propylene glycol to USP standards. Item

> EMD Serono's Boston-area research center is LEED Gold certified, one of only five labs in Massachusetts awarded the rating. Article

> The FDA and the Brookings Institution are evaluating a single-page standard medication-information document to replace the various materials now given to patients. Story

> In The Price of Global Health: Drug Pricing Strategies to Balance Patient Access and the Funding of Innovation ($135), Ed Schoonveld of consultancy ZS Associates says CEOs must take on the difficult process of adding the payer perspective into development processes. Release

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.